Annexin Advances NEXUS Study To Include Anti-VEGF-Treated Patients

The amended NEXUS protocol for Annexin's Vanexin in retinal vein occlusion now includes patients who received one anti-VEGF injection. Germany's BfArM approved the expansion, while UK regulatory approval from the MHRA remains pending.